Author:
Mathew Joseph L.,Bagga Arvind,Sinha Aditi,Sinha Rajiv,Sankar Janani
Publisher
Springer Science and Business Media LLC
Subject
Pediatrics, Perinatology and Child Health
Reference3 articles.
1. Christian MT, Webb NJA, Mehta S, et al. Evaluation of daily low-dose prednisolone during upper respiratory tract infection to prevent relapse in children with relapsing steroid-sensitive nephrotic syndrome: The PREDNOS 2 randomized clinical trial. JAMA Pediatr. 2022; 176:236–43.
2. Christian MT, Webb NJ, Woolley RL, et al. Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT. Health Technol Assess. 2022; 26:1–94.
3. Higgins JPT, Savoviæ J, Page MJ, Sterne JAC. Revised Cochrane risk-of-bias tool for randomized trials (RoB 2). Accessed March 13, 2022. Available: https://drive.google.com/file/d/1Q4Fk3HCuBRwIDWTGZa5oH11OdR4Gbhdo/view